Submission Details
| 510(k) Number | K153741 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 28, 2015 |
| Decision Date | March 18, 2016 |
| Days to Decision | 81 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K153741 is an FDA 510(k) clearance for the CLUNGENE Methamphetamine Test, CLUNGENE Morphine Test, CLUNGENE Marijuana Test, a Enzyme Immunoassay, Cannabinoids (Class II — Special Controls, product code LDJ), submitted by Hangzhou Clongene Biotech Co., Ltd. (Hangzhou, CN). The FDA issued a Cleared decision on March 18, 2016, 81 days after receiving the submission on December 28, 2015. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3870.
| 510(k) Number | K153741 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 28, 2015 |
| Decision Date | March 18, 2016 |
| Days to Decision | 81 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | LDJ — Enzyme Immunoassay, Cannabinoids |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3870 |